Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
about
Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model.Defining nephrotic syndrome from an integrative genomics perspective.Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.Complement Activation in Patients with Focal Segmental Glomerulosclerosis.Compound effects of aging and experimental FSGS on glomerular epithelial cellsAn emerging molecular understanding and novel targeted treatment approaches in pediatric kidney diseases.Recurrent focal segmental glomerulosclerosis after kidney transplantation.Focal Segmental Glomerulosclerosis.Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease.Nonfunction of the ECT2 gene may cause renal tubulointerstitial injury leading to focal segmental glomerulosclerosis.Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).Pharmacological and Genetic Inhibition of Downstream Targets of p38 MAPK in Experimental Nephrotic Syndrome.Investigational drugs in development for focal segmental glomerulosclerosis.The Efficacy of Puromycin and Adriamycin for Induction of Glomerular Failure in Larval Zebrafish Validated by an Assay of Glomerular Permeability Dynamics.Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
P2860
Q33622259-C1038193-808D-4D97-88A4-64FA59FC0F50Q33943563-9E746967-A2B1-4488-BEE7-6A7A106A859BQ34560989-05F5ECF4-F5D3-4F1F-9DFC-3008499BBCACQ35704498-461AA520-5702-4891-8955-D7A05B0FA8F7Q35763276-C02E3F67-44B6-4BB6-813B-1362D3E0224DQ37715505-54D3761C-908B-4B60-B950-594138558CDFQ38232593-5DA81D97-0F75-4D5B-B038-9DA021C6B32CQ38359297-3D169413-CA4B-404C-A310-4CF814D81878Q38938623-06F5809D-A141-4E33-A411-193552CA5677Q39366213-DA83FC99-7EB3-4CA4-9B2C-EAABD18D1702Q42096387-9B631A7E-675E-4185-BE32-BAEAA21DA1C5Q46399341-F642F86F-D70D-4741-96FE-2F421FC2D538Q47350783-385A03BD-5F55-46CB-8A76-63FF9018CFDFQ51840896-A0A4515E-7B75-4881-9C03-98B46C24329EQ52685434-B9860F02-D9E0-41E7-940D-4A4E58FD8B00Q53742806-DD046E67-9EEF-4C36-902D-6A9020F1558D
P2860
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@en
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@nl
type
label
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@en
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@nl
prefLabel
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@en
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@nl
P2093
P2860
P1476
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
@en
P2093
Howard Trachtman
Jeremy Kiffel
Yael Rahimzada
P2860
P304
P356
10.1053/J.ACKD.2011.03.005
P577
2011-09-01T00:00:00Z